Author

D. Repantis

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Feeling safe: an empirical-ethical analysis of vulnerability in (es)ketamine treatment

Treatments with acute consciousness-altering effects, such as (es)ketamine, place patients in a state of heightened vulnerability with reduced capacity for self-advocacy and self-regulation. Since feeling safe is a precondition for consenting to begin, and remaining in, treatment, this raises distinct ethical demands o...

Adrian Kind, Josephine Görke, Hannah Smirr et al. · BMC Medical Ethics · 0 citations

Review Open access Sep 2026

717. Clinical trials, ethical dimensions, and the pathway of MDMA-assisted therapy in PTSD

Ethical concerns arise from MDMA’s affective and cognitive effects, which may influence vulnerability in the patient–therapist relationship, the emergence of memory and belief changes, and participants’ understanding of the intervention, as well as therapist's implicit and explicit therapy models.

C. Poppe, D. Repantis · International Journal of Neu... · 0 citations